Business Wire
03 Dec 2025, 21:01 UTC · 47w ago
Verdict
Headline takes no side. We score DCTH +0.60 — strongly bullish.
+0.60strongly bullish
More positive than 71% of ticker scores this week
Which stocks this story touches
More positive than 71% of ticker scores this week
The company announced the publication of a retrospective study on its liver cancer treatment, which typically serves as positive clinical validation.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
16h ago
+49.1%
Price agrees with the score
$14.40 vs $9.66 close before publication (Dec 3) · not market-adjusted
DCTH chart →
